Gavi/2012/Doune Porter GAVI, THE VACCINE ALLIANCE Institute of Medicine, Forum on PPP Adrien de Chaisemartin November, 2014, Washington DC www.gavi.org
Gavi/2013/Evelyn Hockstein ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing access to immunisation in poor countries 2 #vaccineswork
GAVI S PARTNERSHIP MODEL Building on the comparative advantages of both public and private partners 3 #vaccineswork
GAVI S VACCINATION PROGRAMMES: AN OVERVIEW Refers to the first Gavi-supported introduction of each vaccine. 4 #vaccineswork
VACCINE INTRODUCTIONS 2011 13 93 introductions and campaigns across 52 countries 73 Eligible countries Source: Gavi data as of December 2013. 5 #vaccineswork
GAVI SUPPORT BRINGS SUCCESS Delivered together by Gavi, the Vaccine Alliance million children immunised* million future deaths averted* vaccine introductions and campaigns** * As of December 2013. ** As of September 2014. 6 #vaccineswork
Gavi/2013/Evelyn Hockstein PPP model: Lessons learnt Global level: Significant successes from the Public-Private model Country-level: significant untapped potential 7 #vaccineswork
Gavi s PPP model: Critical innovation at the global level Resource mobilisation Market shaping 1 2 IFFIm vaccine bonds frontloading long-term government commitments has doubled resources available for programmes Gavi Matching Fund designed to leverage and double the impact of private sector funds 3 4 Advance Market Commitment (AMC) accelerating affordable supply of appropriate vaccines for developing countries Creation of a reliable market for vaccines in developing countries through forecasted and pooled demand 8 #vaccineswork
1 IFFIM FRONTLOADING Long-term donor pledges are converted into immediately available funding for immunisation Source: World Bank, 2013 9 #vaccineswork
2 THE GAVI MATCHING FUND Public-private partnership initiative brings private-sector funding, visibility and innovation to Gavi programmes Contributions From private-sector partners and their customers, employees and business partners Matches From the UK Department for International Development (DFID) and the Bill & Melinda Gates Foundation US$ 213 million raised 2011 2014* * As of July 2014. 10 #vaccineswork
(from left to right): Gavi/2014/D.Rowe, Gavi/2007/Atul Loke, Gavi/2012/Sala Lewis 3 ADVANCE MARKET COMMITMENT (AMC) Accelerating the manufacture and delivery of vaccines Donors commit funds for new vaccines that meet stringent criteria and are requested by developing countries, at pre-agreed price Manufacturers get incentive to invest in R&D legally committing to supply vaccines at lower prices in the long term Developing countries and Gavi pay long-term, lower price for the vaccines 11 #vaccineswork
3 PNEUMOCOCCAL VACCINES THROUGH THE AMC Cumulative number of introductions and doses shipped per year Source: Gavi data as of April 2014. 12 #vaccineswork
4 TIERED PRICING ENSURES LOWER COST 2013 vaccine prices per dose (US$) 13 #vaccineswork
VACCINE SUPPLY IN 2001 5 suppliers from 5 countries of production 2001 Source: UNICEF Supply Division. 14 #vaccineswork
VACCINE SUPPLY IN 2013 13 suppliers from 10 countries of production 2013 Source: UNICEF Supply Division, 2014. 15 #vaccineswork
Gavi/2013/Evelyn Hockstein PPP model: Lessons learnt Global level: Significant successes from the Public-Private model Country-level: significant untapped potential 16 #vaccineswork
21.8 MILLION CHILDREN UNDER-IMMUNISED Number of children globally not receiving the third dose of DTP-containing vaccine, 2013 almost 85% are in Gavi-supported countries 21.8 million Source: WHO/UNICEF coverage estimates 2013 revision, July 2014. 17 #vaccineswork
Closing the immunization gap will require strengthening the partnership at the country level Diana Sava Proportion of fully immunized children, by region, 2011, Madagascar (MDG 2013) Analanjirofo Sofia Melaky Boeny Betsiboka Alaotra-Mangoro Analam anga Bongolava Itasy Atsinanana Vakinankaratra Menabe Amoron'i mania Haute matsiatra Vatovavy Fitovinany Ihorombe Atsimo-Andrefana Anosy Androy Atsimo-Atsinana Region Fully immunized <40 40-50 50-60 60+
Critical questions for Gavi s partnership How to better leverage the presence of technical partners on the ground: Development sector: WHO, UNICEF, World Bank Public sector: Bilateral donors involved in fields related to immunisation (MNCH in particular) Private sector: Consumer goods, mining etc. What coordination mechanism? What funding flows? What role for the Gavi Secretariat? 19 #vaccineswork
Early answers The Gavi Alliance Business Plan : Definition of roles and responsibility of Alliance partners in 73 Gavi countries Provision of funding to partners where gaps are identified Regional and local forums for coordination of partners support Development of a private sector strategy: Engagement at global level to catalyze partnerships at local levels Pilots in a few countries (mhealth) Evolution of the Secretariat Improvement of convening and coordination role at country level Dedicated resources in the country programme team Need the right trade off between lean stewardship or further involvement in implementation/ risk mitigation at country level 20